ADD CONDITION

items per page

Aspercreme Lidocaine Foot (diabetic)

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2018
Label revision date
October 23, 2023
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2018
Label revision date
October 23, 2023
Manufacturer
Chattem, Inc.
Registration number
M017
NDC root
41167-0597

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Aspercreme is a foot cream that combines maximum strength lidocaine (a local anesthetic) with moisturizing properties to help soothe your skin. It is designed to temporarily relieve minor pain, making it a helpful option for those experiencing discomfort in their feet.

By applying Aspercreme, you can enjoy both pain relief and hydration, allowing you to feel more comfortable throughout your day.

Uses

You can use this medication to temporarily relieve minor pain. It’s designed to help you feel more comfortable when dealing with everyday aches and discomforts. Rest assured, there are no known teratogenic effects (which means it doesn’t cause birth defects) associated with this medication.

Dosage and Administration

For adults and children over 12 years old, you should apply a thin layer of the medication to the affected area every 6 to 8 hours. However, make sure not to exceed three applications within a 24-hour period. After applying, gently massage the medication into the painful area until it is fully absorbed into your skin.

If you are considering using this medication for a child who is 12 years old or younger, it’s important to consult a doctor first to ensure it’s safe and appropriate for them.

What to Avoid

You should avoid using this product if you have serious foot problems like ulcers or infections, numbness, or a reduced ability to feel pain. It's also important not to apply it on cut, irritated, or swollen skin, or on puncture wounds. If you need to use it for more than one week, consult your doctor first.

While using this product, make sure to keep it away from your eyes and mucous membranes. Avoid tightly bandaging the area or applying local heat, such as heating pads or medicated patches. Additionally, do not use it alongside other topical pain relievers, as this can increase the risk of side effects or complications.

Side Effects

You should be aware that this product is for external use only and should not be used if you have serious foot problems, such as ulcers or infections, or if you experience numbness or a reduced ability to feel pain. Avoid applying it to cut, irritated, or swollen skin, and do not use it on puncture wounds or for more than one week without consulting a doctor.

While using this product, make sure to keep it away from your eyes and mucous membranes, and do not apply tight bandages or heat to the treated area. If you notice any worsening of your condition, redness, irritation, or if symptoms persist for more than seven days or return shortly after improvement, stop using the product and consult a doctor. If swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

This product is for external use only, so please avoid using it on serious foot problems like ulcers or infections, or if you have numbness that affects your ability to feel pain. Do not apply it to cut, irritated, or swollen skin, and avoid using it on puncture wounds. It's important to follow the directions carefully and not use it for more than one week without consulting your doctor.

While using this product, make sure it does not come into contact with your eyes or mucous membranes. Avoid tightly bandaging the area or applying heat, such as heating pads, and do not use it alongside other topical pain relievers. If your condition worsens, if you notice redness or irritation, or if symptoms persist for more than seven days or return shortly after improvement, stop using the product and contact your doctor.

Keep this product out of reach of children. If swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed a medication and you suspect an overdose, it’s important to act quickly. Contact a medical professional or call a Poison Control Center immediately for guidance. They can provide you with the necessary steps to take based on the specific situation.

Signs of an overdose can vary, but they may include unusual symptoms that are not typical for the medication. If you notice any concerning changes in behavior or health, don’t hesitate to seek immediate medical attention. Your safety is the top priority, so getting help quickly can make a significant difference.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking professional advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If you have a child who is 12 years old or younger, it's important to consult with a doctor before using this medication. For children over 12 years and adults, you can apply a thin layer of the product to the affected area every 6 to 8 hours. However, be sure not to exceed three applications within a 24-hour period to ensure safety and effectiveness. Always follow these guidelines to help keep your child safe while using this treatment.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken.

Always ensure that your healthcare provider is aware of any existing health conditions or medications, as this can help in making informed decisions about treatment options. Your safety and well-being are the top priority, so don’t hesitate to ask questions or express any concerns.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific situation. They can help monitor your kidney health and make any necessary adjustments to your medications.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Before starting any new medication, including this one, you should discuss your liver health with your healthcare provider. They can help determine the best approach for your treatment and ensure your safety.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the safety and effectiveness of your product, store it at room temperature. It's important to keep it out of reach of children to prevent any accidental ingestion or misuse. After each use, make sure to close the cap tightly to maintain its integrity and prevent contamination. Following these simple steps will help you use the product safely and effectively.

Additional Information

You should apply a thin layer of the medication to the affected area every 6 to 8 hours, but do not exceed three applications in a 24-hour period. If you are pregnant or breastfeeding, it's important to consult a healthcare professional before using this product.

Make sure to keep the medication out of reach of children. If it is swallowed, seek medical help or contact a Poison Control Center immediately.

FAQ

What is Aspercreme used for?

Aspercreme is used to temporarily relieve minor pain.

How should I apply Aspercreme?

Apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 applications in a 24-hour period. Massage it into the skin until fully absorbed.

Can children use Aspercreme?

Children 12 years or younger should ask a doctor before use.

What precautions should I take when using Aspercreme?

Do not allow contact with eyes or mucous membranes, do not bandage tightly, and do not use with other topical analgesics.

What should I do if I experience side effects?

Stop use and ask a doctor if your condition worsens, if redness or irritation develops, or if symptoms persist for more than 7 days.

Is Aspercreme safe to use during pregnancy or breastfeeding?

If you are pregnant or breastfeeding, ask a health professional before use.

What should I avoid while using Aspercreme?

Avoid using Aspercreme on serious foot problems, cut or irritated skin, and do not use for more than one week without consulting a doctor.

What should I do if Aspercreme is swallowed?

If swallowed, get medical help or contact a Poison Control Center immediately.

Packaging Info

Below are the non-prescription pack sizes of Aspercreme Lidocaine Foot (diabetic) (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aspercreme Lidocaine Foot (diabetic).
Details

Drug Information (PDF)

This file contains official product information for Aspercreme Lidocaine Foot (diabetic), including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area every 6 to 8 hours. The total number of applications must not exceed 3 times within a 24-hour period. It is important to massage the medication into the painful area until it is thoroughly absorbed into the skin.

For children 12 years of age or younger, it is advised to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with serious foot problems, including ulcers or infections, should not use this product due to the risk of exacerbating these conditions. Additionally, individuals with numbness or a reduced ability to feel pain are advised against use, as this may lead to unrecognized injury. Application on cut, irritated, or swollen skin is contraindicated to prevent further irritation or complications. The product should not be applied to puncture wounds, as this may hinder proper healing. Prolonged use beyond one week without consulting a healthcare professional is also contraindicated.

During application, it is essential to avoid contact with the eyes and mucous membranes to prevent irritation. Tight bandaging, local heat application (such as heating pads), or the use of a medicated patch on the treated area is not recommended. Concurrent use with other topical analgesics is contraindicated to avoid potential adverse interactions.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with serious foot problems, including ulcers or infections, as well as those experiencing numbness or a reduced ability to feel pain. It should not be applied to cut, irritated, or swollen skin, nor on puncture wounds. Prolonged use beyond one week without consulting a healthcare professional is not recommended.

When utilizing this product, it is imperative to adhere strictly to the provided directions. Users must read and follow all warnings and instructions on the carton. Care should be taken to avoid contact with the eyes and mucous membranes. Additionally, the area of application should not be tightly bandaged, nor should local heat sources, such as heating pads or medicated patches, be applied concurrently. The use of other topical analgesics at the same time is also contraindicated.

Patients should discontinue use and consult a healthcare provider if the condition worsens, if redness occurs, if irritation develops, or if symptoms persist for more than seven days or resolve only to recur within a few days.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated in individuals with serious foot problems, such as ulcers or infections, as well as those experiencing numbness or a reduced ability to feel pain. The product should not be applied to cut, irritated, or swollen skin, nor should it be used on puncture wounds. Additionally, it is advised that patients do not use the product for more than one week without consulting a healthcare professional.

While using this product, patients should avoid contact with the eyes and mucous membranes. It is also important not to bandage the area tightly or apply local heat, such as heating pads or medicated patches, to the site of application. Concurrent use with other topical analgesics is not recommended.

Patients are advised to discontinue use and consult a doctor if their condition worsens, if redness or irritation develops, or if symptoms persist for more than seven days or resolve only to recur within a few days.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Aspercreme Lidocaine Foot (diabetic) (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Aspercreme Lidocaine Foot (diabetic).
Details

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional prior to use. For adolescents and children over 12 years, the recommended dosage is to apply a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications within a 24-hour period.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to discuss their individual circumstances with a healthcare provider to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and contact dermatitis. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is essential for patients to use the medication only as directed. They should be encouraged to read and follow all directions and warnings provided on the carton to ensure safe and effective use.

Healthcare providers should also inform patients to avoid contact with the eyes and mucous membranes, as this could lead to irritation or other adverse effects. Additionally, patients should be cautioned against bandaging the area tightly or applying local heat, such as heating pads or medicated patches, to the site of application, as this may exacerbate side effects or lead to complications.

Finally, it is important to advise patients not to use this medication concurrently with other topical analgesics, as this could increase the risk of adverse reactions.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature to maintain its efficacy. It is essential to keep the product out of reach of children to prevent accidental ingestion. After each use, the cap must be closed tightly to preserve the integrity of the product.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the affected area every 6 to 8 hours, not exceeding three applications within a 24-hour period. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. Additionally, it is important to keep the product out of reach of children; if ingested, medical assistance or contact with a Poison Control Center should be sought immediately.

No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Aspercreme Lidocaine Foot (diabetic), including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Aspercreme Lidocaine Foot (diabetic), retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.